Homocysteine modulates the proteolytic potential of human vascular endothelial cells
- 26 March 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 316 (1) , 170-176
- https://doi.org/10.1016/j.bbrc.2004.02.027
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial CellsCirculation, 2001
- Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemiaJournal of Clinical Investigation, 2000
- Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic EvidenceAnnals of Internal Medicine, 1999
- Homocysteine decreases endothelin‐1 production by cultured human endothelial cellsEuropean Journal of Biochemistry, 1999
- Hyperhomocysteinemia induces elastolysis in minipig arteries: Structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazideMatrix Biology, 1998
- Hyperhomocysteinemia-Induced Vascular Damage in the MinipigCirculation, 1995
- Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulumBlood, 1993
- Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)Biochemical Journal, 1991
- Morphologic Studies in a Patient with Homocystinuria due to 5,10-Methylenetetrahydrofolate Reductase DeficiencyPediatric Research, 1976
- Pathological findings in homocystinuriaJournal of Clinical Pathology, 1964